MTOR and acute myeloid leukemia: In acute myeloid leukemia (AML), prazosin inhibited viability and induced cell cycle arrest in U937 and HL60 cell lines, reducing phosphorylated Akt (p-Akt) and mTOR (p-mTOR) [71].